Meridian Bioscience Initiates Guidance for FY 2014, Reaffirms FY 2013 Guidance | GenomeWeb

NEW YORK (GenomeWeb News) – Meridian Bioscience today initiated sales and earnings guidance for its Fiscal Year 2014, while it reiterated prior guidance for full-year fiscal 2013.

For FY 2014, the Cincinnati-based company said that net sales are anticipated to be in the range of $203 million and $208 million. It guided to EPS of between $.98 and $1.03, saying net earnings are anticipated to increase between 10 and 15 percent compared to fiscal 2013.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In PNAS this week: map of UV-induced damage in yeast genome, comparative epigenomics uncovers plant lacking key DNA methyltransferase enzyme, and more.

Researchers kick off their second Queer in STEM survey to examine what can make STEM careers welcoming, Wired reports.

A startup company is offering a test to analyze soil samples from farms for pathogens.

Prosecutors seek to introduce evidence from low-template DNA analysis in a murder case in upstate New York, the New York Times reports.